# U S Global Investors Inc: financial statements, quarterly

GROW · Nasdaq · CIK 754811 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/grow.md) · [Financials](/companies/grow/financials.md) · [Filings](/companies/grow/filings.md) · [Insiders](/companies/grow/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/grow/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,133](/filings/0001437749-24-033940.md) | [2,818](/filings/0001437749-25-003577.md) | [2,593](/filings/0001437749-25-015578.md) | [2,440 d](/filings/0001437749-25-028574.md) | [2,157](/filings/0001437749-25-034452.md) | [2,231](/filings/0001437749-26-004918.md) | [2,103](/filings/0001437749-26-019757.md) | [4,353 d](/filings/0001437749-26-029613.md) | [2,251](/filings/0001437749-25-034452.md) | [2,510](/filings/0001437749-26-004918.md) | [2,762](/filings/0001437749-26-019757.md) | [6,875 d](/filings/0001437749-26-029613.md) |
| Operating income | $k | [215](/filings/0001437749-24-033940.md) | [192](/filings/0001437749-25-003577.md) | [(488)](/filings/0001437749-25-015578.md) | [(398) d](/filings/0001437749-25-028574.md) | [(559)](/filings/0001437749-25-034452.md) | [(539)](/filings/0001437749-26-004918.md) | [(893)](/filings/0001437749-26-019757.md) | [(996) d](/filings/0001437749-26-029613.md) | [(515)](/filings/0001437749-25-034452.md) | [(88.0)](/filings/0001437749-26-004918.md) | [88.0](/filings/0001437749-26-019757.md) | [(88.0) d](/filings/0001437749-26-029613.md) |
| Interest expense | $k | [1.0](/filings/0001437749-23-034447.md) | [0.0](/filings/0001437749-24-003526.md) | [1.0](/filings/0001437749-24-015690.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [(65.0)](/filings/0001437749-24-033940.md) | [436](/filings/0001437749-25-003577.md) | [75.0](/filings/0001437749-25-015578.md) | [136 d](/filings/0001437749-25-028574.md) | [121](/filings/0001437749-25-034452.md) | [(30.0)](/filings/0001437749-26-004918.md) | [137](/filings/0001437749-26-019757.md) | [(157) d](/filings/0001437749-26-029613.md) | [337](/filings/0001437749-25-034452.md) | [1,381](/filings/0001437749-26-004918.md) | [(844)](/filings/0001437749-26-019757.md) | [(45.0) d](/filings/0001437749-26-029613.md) |
| Net income | $k | [(176)](/filings/0001437749-25-015578.md) | [1,229](/filings/0001437749-25-015578.md) | [(35.0)](/filings/0001437749-25-015578.md) | [315 d](/filings/0001437749-25-028574.md) | [315](/filings/0001437749-26-019757.md) | [(86.0)](/filings/0001437749-26-019757.md) | [(382)](/filings/0001437749-26-019757.md) | [(181) d](/filings/0001437749-26-029613.md) | [1,507](/filings/0001437749-26-019757.md) | [(846)](/filings/0001437749-26-019757.md) | [2,677](/filings/0001437749-26-019757.md) | [(283) d](/filings/0001437749-26-029613.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001437749-24-033940.md) | [0.09](/filings/0001437749-25-003577.md) | [0.00](/filings/0001437749-25-015578.md) | not reported | [0.02](/filings/0001437749-25-034452.md) | [(0.01)](/filings/0001437749-26-004918.md) | [(0.03)](/filings/0001437749-26-019757.md) | not reported | [0.12](/filings/0001437749-25-034452.md) | [(0.07)](/filings/0001437749-26-004918.md) | [0.21](/filings/0001437749-26-019757.md) | not reported |
| Basic EPS | $ per share | [(0.01)](/filings/0001437749-24-033940.md) | [0.09](/filings/0001437749-25-003577.md) | [0.00](/filings/0001437749-25-015578.md) | not reported | [0.02](/filings/0001437749-25-034452.md) | [(0.01)](/filings/0001437749-26-004918.md) | [(0.03)](/filings/0001437749-26-019757.md) | not reported | [0.12](/filings/0001437749-25-034452.md) | [(0.07)](/filings/0001437749-26-004918.md) | [0.21](/filings/0001437749-26-019757.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [26.8](/filings/0001437749-23-034447.md) | [27.5](/filings/0001437749-24-003526.md) | [27.5](/filings/0001437749-24-015690.md) | [27.4](/filings/0001437749-25-028574.md) | [27.3](/filings/0001437749-24-033940.md) | [26.0](/filings/0001437749-25-003577.md) | [26.3](/filings/0001437749-25-015578.md) | [24.6](/filings/0001437749-26-029613.md) | [24.6](/filings/0001437749-25-034452.md) | [25.2](/filings/0001437749-26-004918.md) | [24.6](/filings/0001437749-26-019757.md) | [24.3](/filings/0001437749-26-029613.md) |
| Current assets | $m | [40.5](/filings/0001437749-23-034447.md) | [40.4](/filings/0001437749-24-003526.md) | [40.9](/filings/0001437749-24-015690.md) | [40.3](/filings/0001437749-25-028574.md) | [40.1](/filings/0001437749-24-033940.md) | [40.0](/filings/0001437749-25-003577.md) | [39.3](/filings/0001437749-25-015578.md) | [39.1](/filings/0001437749-26-029613.md) | [39.1](/filings/0001437749-25-034452.md) | [38.7](/filings/0001437749-26-004918.md) | [38.1](/filings/0001437749-26-019757.md) | [37.6](/filings/0001437749-26-029613.md) |
| Total assets | $m | [54.1](/filings/0001437749-24-033940.md) | [53.6](/filings/0001437749-25-003577.md) | [52.8](/filings/0001437749-25-015578.md) | [52.0](/filings/0001437749-25-028574.md) | [51.1](/filings/0001437749-25-034452.md) | [50.1](/filings/0001437749-26-004918.md) | [48.8](/filings/0001437749-26-019757.md) | [48.1](/filings/0001437749-26-029613.md) | [48.9](/filings/0001437749-25-034452.md) | [47.2](/filings/0001437749-26-004918.md) | [48.9](/filings/0001437749-26-019757.md) | [48.0](/filings/0001437749-26-029613.md) |
| Current liabilities | $m | [2.8](/filings/0001437749-23-034447.md) | [2.2](/filings/0001437749-24-003526.md) | [2.3](/filings/0001437749-24-015690.md) | [2.2](/filings/0001437749-25-028574.md) | [1.9](/filings/0001437749-24-033940.md) | [2.0](/filings/0001437749-25-003577.md) | [1.8](/filings/0001437749-25-015578.md) | [1.9](/filings/0001437749-26-029613.md) | [1.9](/filings/0001437749-25-034452.md) | [2.0](/filings/0001437749-26-004918.md) | [1.8](/filings/0001437749-26-019757.md) | [1.9](/filings/0001437749-26-029613.md) |
| Total liabilities | $m | [3.4](/filings/0001437749-23-034447.md) | [2.7](/filings/0001437749-24-003526.md) | [2.9](/filings/0001437749-24-015690.md) | [3.0](/filings/0001437749-25-028574.md) | [2.7](/filings/0001437749-24-033940.md) | [2.8](/filings/0001437749-25-003577.md) | [2.7](/filings/0001437749-25-015578.md) | [2.9](/filings/0001437749-26-029613.md) | [2.9](/filings/0001437749-25-034452.md) | [3.1](/filings/0001437749-26-004918.md) | [2.9](/filings/0001437749-26-019757.md) | [2.9](/filings/0001437749-26-029613.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [50.5](/filings/0001437749-25-015578.md) | [50.7](/filings/0001437749-25-015578.md) | [49.7](/filings/0001437749-25-015578.md) | [49.0](/filings/0001437749-26-029613.md) | [48.4](/filings/0001437749-25-015578.md) | [47.3](/filings/0001437749-26-019757.md) | [46.1](/filings/0001437749-26-019757.md) | [45.2](/filings/0001437749-26-029613.md) | [46.0](/filings/0001437749-25-034452.md) | [44.2](/filings/0001437749-26-019757.md) | [46.0](/filings/0001437749-26-019757.md) | [45.1](/filings/0001437749-26-029613.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [884](/filings/0001437749-24-033940.md) | [26.0 d](/filings/0001437749-25-003577.md) | [(57.0) d](/filings/0001437749-25-015578.md) | [137 d](/filings/0001437749-25-028574.md) | [16.0](/filings/0001437749-25-034452.md) | [(399) d](/filings/0001437749-26-004918.md) | [(425) d](/filings/0001437749-26-019757.md) | [(14.0) d](/filings/0001437749-26-029613.md) | [(32.0)](/filings/0001437749-25-034452.md) | [256 d](/filings/0001437749-26-004918.md) | [295 d](/filings/0001437749-26-019757.md) | [223 d](/filings/0001437749-26-029613.md) |
| Capital expenditure | $k | [59.0](/filings/0001437749-24-033940.md) | [52.0 d](/filings/0001437749-25-003577.md) | [68.0 d](/filings/0001437749-25-015578.md) | [34.0 d](/filings/0001437749-25-028574.md) | [0.0](/filings/0001437749-24-033940.md) | [7.0 d](/filings/0001437749-26-004918.md) | [(1.0) d](/filings/0001437749-26-019757.md) | [1.0 d](/filings/0001437749-26-029613.md) | not reported | not reported | [20.0 d](/filings/0001437749-26-019757.md) | [20.0 d](/filings/0001437749-26-029613.md) |
| Dividends paid | $k | [326](/filings/0001437749-24-033940.md) | [322 d](/filings/0001437749-25-003577.md) | [317 d](/filings/0001437749-25-015578.md) | [313 d](/filings/0001437749-25-028574.md) | [308](/filings/0001437749-25-034452.md) | [305 d](/filings/0001437749-26-004918.md) | [299 d](/filings/0001437749-26-019757.md) | [296 d](/filings/0001437749-26-029613.md) | [292](/filings/0001437749-25-034452.md) | [287 d](/filings/0001437749-26-004918.md) | [283 d](/filings/0001437749-26-019757.md) | [279 d](/filings/0001437749-26-029613.md) |
| Share repurchases | $k | [611](/filings/0001437749-24-033940.md) | [560 d](/filings/0001437749-25-003577.md) | [577 d](/filings/0001437749-25-015578.md) | [424 d](/filings/0001437749-25-028574.md) | [530](/filings/0001437749-25-034452.md) | [591 d](/filings/0001437749-26-004918.md) | [453 d](/filings/0001437749-26-019757.md) | [395 d](/filings/0001437749-26-029613.md) | [390](/filings/0001437749-25-034452.md) | [666 d](/filings/0001437749-26-004918.md) | [552 d](/filings/0001437749-26-019757.md) | [364 d](/filings/0001437749-26-029613.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.9](/filings/0001437749-23-034447.md) | [14.9](/filings/0001437749-24-003526.md) | [14.7](/filings/0001437749-24-015690.md) | [14.5](/filings/0001437749-24-033940.md) | [14.3](/filings/0001437749-25-003577.md) | [14.1](/filings/0001437749-25-015578.md) | [13.7](/filings/0001437749-25-034452.md) | [13.5](/filings/0001437749-26-004918.md) | [13.0](/filings/0001437749-26-019757.md) | [13.0](/filings/0001437749-25-034452.md) | [12.8](/filings/0001437749-26-004918.md) | [12.6](/filings/0001437749-26-019757.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,484,211 at 2026-02-12, from the cover of the [10-Q filed 2026-02-20](/filings/0001437749-26-004918.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.